Table 1 Analysis of clinical factors in relation to the presence of mutations in the core protein in 29 patients with chronic hepatitis B virus infection
From: The role of mutations in core protein of hepatitis B virus in liver fibrosis
Clinical factor | All patients (n = 29) | Wild Type (n = 10) | Mutant (n = 19) | P value |
|---|---|---|---|---|
Age* (Years) | 42 ± 9 | 43 ± 8 | 41 ± 9 | 0.5 |
ALT* (IU/l) | 41 ± 16 | 34 ± 13 | 44 ± 16 | 0.09 |
HBV DNA* (Log copies/ml) | 4.2 ± 0.8 | 4.0 ± 0.9 | 4.3 ± 0.8 | 0.4 |
HAI score* | 5.7 ± 2.4 | 5.1 ± 2.2 | 6.1 ± 2.4 | 0.2 |
Stage of Fibrosis* | 1.6 ± 1.3 | 1.0 ± 0.8 | 1.9 ± 1.4 | 0.05 |